Authors: Pichaet Wiriyachitra, Sirithip Wiriyachitra, Siriporn Wonghiranyingyot, Ampai Panthong, Ganigah Ruanjahn, Souwalak Phongpaichit, Wilawan Mahabusarakam.
ByeByeHIV is defined as the condition in which HIV/AIDS-infected individuals can reduce their HIV load to undetectable levels without the consumption of antiviral drugs and enjoy healthy living. It also refers to the condition where HIV infected individuals, who have consumed antiviral drugs as the treatment but can no longer tolerate the drugs’ side effects, can stop taking the drugs and enjoy living a healthy life with undetectable HIV. ByeByeHIV innovation is composed of synergistic extracts from 5 types of edible plants, namely mangosteen, black sesame, soybean, guava and Centella asiatica. It has been proven effective in stimulating Th1 and Th17 cells, which boosts the potency of killer T cells to eliminate HIVinfected cells. It has also been proven to repair the telomere damage caused by HIV and the side effects of antiviral drugs. The innovation has successfully helped over 6,000 HIV/AIDSinfected individuals increase their CD4 count, decrease viral load, and improve their quality of life. In 2014, the first HIV-infected person volunteered to take the innovation instead of antiviral drugs. His HIV load dropped to an undetectable levels within 12 months and he remained in good health with undetectable HIV for the past 8 years. In 2022, the standard procedure to help HIV/AIDS-infected individuals achieve ByeByeHIV was established. In November 2023, 24 HIV-infected individuals have achieved ByeByeHIV without taking antiviral drugs; among them 6 have stopped taking ByeByeHIV formula and still remain undetected for HIV. 26 HIV/AIDS patients who had taken antiviral drugs for 3-30 years have been able to stop taking antiviral drugs and still enjoy good health, the first person in the group has been off antiviral drugs for 36 months; among them 3 have stopped taking ByeByeHIV formula and still remain undetected for HIV. The number of HIV/AIDS patients who have achieved ByeByeHIV continues to increase in Thailand. We are now advocating this ByeByeHIV innovation as the first safe and effective plant-based immunotherapy to benefit HIV/AIDS-
infected individuals globally. In the presentation, there will be additional information on the mode of action of the innovation, the blood profiles both before and after and the time spent to achieve ByeByeHIV of the 50 infected individuals.
Professor Pichaet Wiriyachitra is the CEO of Asian Phytoceuticals Public Company Limited, a company listed in Stock Exchange of Thailand, to engage in research, development and commercialization of health products derived natural extracts. Dr.Pichaet received the BSc.Hons (Organic Chemistry) from University of Western Australia in 1970 and Ph.D. (Organic Chemistry) from University of Tasmania in 1972. He was a NIH Post- doctoral Fellow at University of Connecticut, America in 1974 and a NSF Post-doctoral Fellow at University of Pennsylvania, America in 1976. His research interests in the Prince of Songkla University and Chiang Mai University in Thailand include the development of Balancing Immunity (BIM) products for autoimmune symptoms and immune- deficient symptoms.
View/Download pdf